High Net Worth Advisory Group LLC

SEC CIK: 0001919142
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

CADL holding history

Candel Therapeutics, Inc. in every 13F filed by High Net Worth Advisory Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CADL overview All 13F holders of CADL Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of CADL by High Net Worth Advisory Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−300−100.0%	Sold out	Holders
Q1 2022	300	$2.00K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	300	$2.00K	<0.1%	–	No prior filing	Holders